Amedisys Inc

Amedisys — Q1 2018 Earnings Presentation

20 slides from Amedisys's earnings presentation, May 7, 2018

  1. Slide 1: Amedisys First Quarter 2018 Earnings Call Supplemental Slides

    Exhibit 99.2 Amedisys First Quarter 2018 Earnings Call Supplemental Slides th 1 May 8 2018

  2. Slide 2: Forward-looking statements

    Forward-looking statements This presentation may include forward-looking statements as defined by the Private www.amedisys.com Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a NASDA

  3. Slide 3: Our Key Areas of Focus

    Our Key Areas of Focus Strategic areas of focus for 2018 and beyond 1 2 3 4 5 Organic Recruiting / Clinical Impact Capacity M&A Growth Retention Initiatives and Productivity • Hospice: Continued • Fifth straight quarter • Quality: Amedisys • Since April 2017, • Preference to acquire impressive growt

  4. Slide 4: Highlights and Summary Financial Results (Adjusted): 1Q 2018

    Highlights and Summary Financial Results (Adjusted): 1Q 2018 (1) Same store Home Health total admissions up (+4%). Hospice (+5% same store admissions) and Personal Care (+27% billable hours) continue their strong growth 1Q’18 1Q’18 • Net debt: ($32.1M) • Revenue Growth: +9% • Leverage ratio: (0.2)x

  5. Slide 5: Our Revenue Sources

    OUR REVENUE SOURCES Amedisys Consolidated Revenue Home Health Revenue Hospice Revenue 4.5% 5.6% 16.9% 24.4% 11.0% 71.1% 72.1% 94.4% Home Health Hospice Personal Care Medicare FFS Private Episodic Per Visit Medicare FFS Private • Medicare FFS: Paid episodically over a 60 day Per Day Reimbursement: ep

  6. Slide 6: Home Health and Hospice Segment (Adjusted) – 1Q 2018

    Home Health and Hospice Segment (Adjusted) – 1Q 2018(1) Home health growth continues to move in the right direction; Hospice continues with double digit ADC growth HOME HEALTH HOSPICE $ in Millions 1Q17 1Q18 $ in Millions 1Q17 1Q18 Medicare 198.7 205.0 Medicare 80.7 91.8 Non-Medicare 68.8 79.2 Non-M

  7. Slide 7: General & Administrative Expenses – Adjusted

    General & Administrative Expenses – Adjusted (1,2) Impact of G&A cost control materializing as operational efficiencies are realized $ in Millions 1Q17 2Q17 3Q17 4Q17 1Q18 Corp G&A 1Q17 2Q17 3Q17 4Q17 1Q18 Home Health Segment 68.0 68.2 68.2 69.0 67.1 Salary and Benefits 13.9 14.1 13.6 14.7 14.9 Acqu

  8. Slide 8: Star scores continue to trend upwards: Among industry leaders

    Star scores continue to trend upwards: Among industry leaders Quality of Patient Care (QPC) Patient Satisfaction (PS) Metric JAN 18 APR 18 JUL 18 Metric OCT 17 JAN 18 APR 18 Release Release PREVIEW Release Release Release Quality of Patient Satisfaction Patient Care 4.22 4.30 4.38 Star 3.56 3.85 3.9

  9. Slide 9: Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class

    Hospice Quality: Amedisys Hospice Continues to Move Towards Best- in-Class Hospice Item Set (HIS) Preview - May 2018 Jul 2016 - Jun 2017 Discharges 99.9% 99.4% 98.9% 100.0% 98.6% 98.3% 98.4% 97.6% 98.3% 96.0% 96.9% 94.5% 94.8% 95.2% 93.6% 93.7% 90.0% 81.5% 80.0% 70.0% Treatment Beliefs & Values Pain

  10. Slide 10: Operational Excellence: Cost Per Visit (CPV)

    Operational Excellence: Cost Per Visit (CPV) Total CPV decreased due to improvement in clinician productivity Components 1Q’17 4Q’17 1Q’18 YoY Variance Detail Mitigation Plan Salaries $61.48 $61.80 $60.93 ($0.55) YoY decrease driven by Staffing mix optimization, productivity increased productivity a

  11. Slide 11: Driving Top Line Growth

    Driving Top Line Growth All three lines of business continue to grow. Hospice drives another quarter of double digit ADC growth and Home Health total same store volume continue to improve year over year Home Health Hospice Personal Care Total Same Store Volume* ADC Total Hours / Quarter 10,000 20.0%

  12. Slide 12: Debt and Liquidity Metrics

    Debt and Liquidity Metrics Our debt levels remain very low at (0.2x) net leverage ratio, providing us ample flexibility and available liquidity for strategic initiatives and inorganic growth opportunities As of: Outstanding Debt 03/31/18 Term Loan 87.5 Outstanding Revolver / Other Notes Payable 0.4

  13. Slide 13: Cash Flow Statement Highlights

    Cash Flow Statement Highlights (1) $36.2M in free cash flow for the quarter, with $2.3M in capital deployed to M&A opportunities $ in Millions 1Q17 2Q17 3Q17 4Q17 1Q18 GAAP Net Income 15.2 4.5 14.7 (3.7) 27.3 Changes in working capital (8.1) (7.3) 15.8 (11.0) (2.0) Depreciation and amortization 4.4

  14. Slide 14: Income Statement Adjustments

    Income Statement Adjustments (1) Amount of non-GAAP adjustments have substantially decreased Income Statement $000s Line Item 1Q17 2Q17 3Q17 4Q17 1Q18 Revenue Florida ZPIC audit Revenue 6,506 Cost of Service Restructuring activity Cost of service, excluding depreciation and amortization 101 G&A Rest

  15. Slide 15: 2018 Guidance

    2018 Guidance

  16. Slide 16: Amedisys 2018 Guidance

    Amedisys 2018 Guidance Targeting 7% growth in revenue and 13% growth in EBITDA; EPS includes impact of tax reform 2017 2018 $1.54B Revenue $1.60B - $1.64B $1.52B* Adjusted EBITDA $142.2M $158M – $163M Adjusted Earnings per $2.21 $2.97 – $3.08 Share *Adjusted for adoption of new revenue recognition a

  17. Slide 17: Amedisys 2018 Guidance Considerations

    Amedisys 2018 Guidance Considerations Project solid revenue and earnings growth while continuing to invest in people and future organic growth Amedisys Home Health Personal Care Hospice Consolidated • Tax rate ~26 - 27% • Total same store • Total same store • Total billable hours (includes impact fr

  18. Slide 18: Reimbursement Outlook

    Reimbursement Outlook 2018 Reimbursement Impact for Home Health and Hospice Home Health Hospice 2018 2018 Market Basket Update 1.0% Market Basket Update 1.0% Nominal Case Mix Adjustment -0.90 Productivity / Other Adjustment __ Estimated Industry Impact +0.1% Estimated Industry Impact +1.0% Estimated

  19. Slide 19: EBITDA Seasonality

    EBITDA Seasonality Historical Adj. EBITDA Trends* 65.0 60.0 55.0 50.0 45.0 40.0 35.0 30.0 Q1 Q2 Q3 Q4 2016 2017 Q1 Q2 Q3 Q4 • Weather disruption • Highest Completed • Incremental holiday • Incremental holiday • Lower RPE (LUPA) Episodes vs. 1H vs. 1H • Payroll tax reset • Stronger RPE • High PTO • H

  20. Slide 20: EBITDA Seasonality (Unadjusted for Health Insurance and Workers Compensation)

    EBITDA Seasonality (Unadjusted for Health Insurance and Workers Compensation) Historical Adj. EBITDA Trends 40 35 30 25 20 Q1 Q2 Q3 Q4 2016 2017 Q1 Q2 Q3 Q4 • Weather disruption • Highest Completed • Incremental holiday • Incremental holiday • Lower RPE (LUPA) Episodes vs. 1H vs. 1H • Payroll tax re

Amedisys — Q1 2018 Earnings Presentation on 6ix